View in a different locale / language
United States
Legionella are Gram-negative bacteria that proliferate in man-made water systems such as cooling towers, potable water systems, and industrial processes. Although present naturally in lakes and rivers, Legionella becomes a significant health risk when it grows in man‑made water systems. Warm temperatures, stagnation, biofilm formation, and available nutrients create conditions that allow these bacteria to multiply. Legionella bacteria are responsible for Legionellosis, which includes two illnesses: Legionnaires’ disease, a severe form of pneumonia, with ~9% mortality, higher in healthcare settings and Pontiac fever, a milder flu‑like illness Infection occurs through inhalation of aerosolized contaminated water. Among the more than 60 known Legionella species, Legionella pneumophila is responsible for the majority of human infections worldwide. Within this species, serogroup 1 (Lp1) accounts for most outbreaks and sporadic cases.
Legionella thrives in warm water environments, typically between 25°C and 45°C (77°F-113°F). Conditions that promote bacterial growth include stagnation, biofilm development, inadequate disinfection, and complex plumbing systems.
Common sources include:
Because Legionella can spread through aerosolized droplets, contamination in these systems may pose risks to building occupants and surrounding communities.
Routine Legionella monitoring is an essential component of water safety and public health protection. Testing helps identify contamination before it leads to exposure or disease outbreaks.
Key objectives of Legionella testing include:
Regulatory guidance such as ASHRAE Standard 188 requires building owners to implement water management plans to control Legionella growth in potable and non‑potable building water systems.
Water Management Plans (WMPs) are structured programs designed to control conditions that promote Legionella growth. Studies from the U.S. Centers for Disease Control and Prevention indicate that most Legionnaires’ disease outbreaks are associated with deficiencies in building water system management.
ASHRAE Standard 188 defines the industry framework for managing Legionella risks and includes seven core elements:
Accurate Legionella testing begins with proper sampling techniques because the bacteria may exist both in water and within biofilms attached to system surfaces.
Water sampling is the most common monitoring approach. Routine monitoring typically requires a 250 mL sample collected in sterile bottles containing sodium thiosulfate to neutralize disinfectants. For outbreak investigations or confirmatory studies, a larger 1‑liter sample may be collected.
Biofilm or swab sampling is used to investigate colonization sites such as shower heads, faucet aerators, storage tanks, and pipe interiors.
Air or aerosol sampling is less common but may be used during outbreak investigations or when aerosol‑generating equipment such as cooling towers, humidifiers, or spas is suspected as the source of infection.
| Sample Type | Recommended Sample Volume/Type | Typical Applications |
| Water (Potable & Non-Potable) | 250 mL (routine); 1 L (outbreak) | Routine monitoring, cooling towers, potable systems |
| Swab/Biofilm | Swabs from surfaces | Identify colonization and biofilm |
| Air/Aerosol | 100 - 1000 L air samples | Outbreak investigation |
Multiple laboratory methods are available for Legionella detection, each providing different advantages depending on regulatory requirements and response timelines. Legionella detection requires a combination of culture-based and molecular methods to balance regulatory compliance with rapid risk assessment. A combined testing strategy (Combo - vPCR + Culture) is often recommended. Rapid molecular results enable early intervention, while culture confirms compliance and provides regulatory defensibility.
| Method | TAT | Advantages | Limitations | Applications |
| Culture (ISO 11731; CDC; and NY ELAP Methods) |
7 days* | Gold standard; Detects viable Legionella species, including L. pneumophila and its serogroups. | Longer TAT (cannot be rushed); May miss VBNC cells | Compliance, Outbreaks |
| Legiolert® (IDEXX) |
7 days | Simple workflow; Detects viable cells | Detects only L. pneumophila (no serogroups) | Screening |
| PCR - Total Legionella (qPCR) |
Same Day Next Day Standard 2 Days |
Rapid TAT; detects VBNC cells | Cannot distinguish between viable and non-viable cells | Early warning; Surveillance |
| PCR - Viable Legionella (vPCR) |
Same Day Next Day Standard 2 Days |
Rapid TAT; Detects viable Legionella species, including L. pneumophila and its serogroups; Strong correlation with culture | Can only be used as supplement analysis for compliance reporting | Validation; Early warning; Outbreaks; Surveillance |
| Combo (vPCR + Culture) |
Same Day + 7 days | Fast + confirmatory | Culture delay | Risk assessment; Validation; Surveillance; Early warning; Outbreaks |
*TAT may be extended based on colony growth and state regulatory requirements
| System Type | Action Threshold | Reference |
| Cooling Towers | ≥10^4 CFU/L (action); ≥10^5 CFU/L (immediate remediation) | CDC Legionella Control Toolkit (2025); NYSDOH Cooling Tower Regulations - Part 4 (2023) |
| Potable Water | <10^2 CFU/L (control); ≥10^3 CFU/L (action) | WHO-Legionella and the Prevention of Legionellosis (2007); EU guidance – Drinking Water Directive 2020/2184 (2020) |
| Healthcare Water Systems | Zero tolerance or very low levels | CDC (2025); CMS (2107); The Joint Commission (2022) |
| General Building Systems | Trend-based; investigate increasing counts | ASHRAE 188 (2021) |
Contact us to discuss your project goals and learn how our testing solutions can support your data and regulatory needs.